Showing results (341-350 of 6,760) with videos related to

Sort By:
Pageof 676
Clinical Therapeutics|August 24, 2010
Parents' decision-making regarding vaccinating their children against influenza: A web-based surveyEmuella M Flood, Matthew D Rousculp, Kellie J Ryan, et al.
Clinical Therapeutics|August 24, 2010
Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the NetherlandsTjalke A Westra, Robin de Vries, Johannes J Tamminga, et al.
Clinical Therapeutics|July 20, 2010
A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial studyDonald R Mehlisch, Sue Aspley, Stephen E Daniels, et al.
Clinical Therapeutics|July 20, 2010
The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in IranSoha Namazi, Negar Azarpira, Fatemeh Hendijani, et al.
Clinical Therapeutics|July 20, 2010
Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot studyJosé Eustasio Meca-Lallana, Pedro de Mingo-Casado, Manuel Amorin-Díaz, et al.
Clinical Therapeutics|July 20, 2010
Cost-effectiveness of somatropin for the treatment of short children born small for gestational ageTorsten Christensen, Andrew Buckland, Anthony Bentley, et al.
Clinical Therapeutics|July 20, 2010
Cost-effectiveness analysis of 5 years of postoperative adjuvant tamoxifen therapy for Korean women with breast cancer: retrospective cohort study of the Korean breast cancer society databaseJae Jeong Yang, Sue K Park, Lisa Y Cho, et al.
Clinical Therapeutics|November 25, 2010
Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulinKelly J Ko, Veronica Tomor, Brian H Nathanson, et al.
Clinical Therapeutics|October 27, 2010
Dexlansoprazole: A proton pump inhibitor with a dual delayed-release systemChristopher R Emerson, Nino Marzella
Clinical Therapeutics|October 27, 2010
Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testingKay Stubenrauch, Uwe Wessels, Herbert Birnboeck, et al.
Pageof 676